Načítá se...

Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer – a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation

Nitroxoline is an antibiotic by chelating Zn(2+) and Fe(2+) from biofilm matrix. In this study, nitroxoline induced G1 arrest of cell cycle and subsequent apoptosis in prostate cancer cells through ion chelating-independent pathway. It decreased protein levels of cyclin D1, Cdc25A and phosphorylated...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Chang, Wei-Ling, Hsu, Lih-Ching, Leu, Wohn-Jenn, Chen, Ching-Shih, Guh, Jih-Hwa
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741862/
https://ncbi.nlm.nih.gov/pubmed/26447757
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!